Here are five things to know:
1. The company’s 2016 revenue grew 18 percent over 2015, owing in large part to the 46 percent growth in spine revenue.
2. Implanet’s gross margin jumped 54 percent last year.
3. The company reported 2016 sales grew 70 percent in the United States and 33 percent in France.
4. Operating loss improved 10 percent in 2016 and net loss improved 9 percent.
5. The company plans to grow its JAZZ technology platform. There are currently 127 surgeons across France and the United States using the technology, which has regulatory approval in both countries.
More articles on spine devices:
Integra LifeSciences to distribute devices in India—4 notes
Mazor Robotics, Medtronic, Zimmer Biomet & more: 10 device company key notes
Alphatec announces $18.9 private placement—5 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.